Skip to main content

Published locations for Dabrafenib plus trametinib yields long-term benefit in melanoma patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dabrafenib plus trametinib yields long-term benefit in melanoma patients

User login

  • Reset your password
  • /content/dabrafenib-plus-trametinib-yields-long-term-benefit-melanoma-patients
  • /edermatologynews/article/206428/melanoma/dabrafenib-plus-trametinib-yields-long-term-benefit
  • /oncologypractice/article/206428/melanoma/dabrafenib-plus-trametinib-yields-long-term-benefit
  • /hematology-oncology/article/206428/melanoma/dabrafenib-plus-trametinib-yields-long-term-benefit
  • /dermatology/article/206428/melanoma/dabrafenib-plus-trametinib-yields-long-term-benefit-melanoma